These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 22197900)

  • 1. New insights into the pathogenesis of Behçet's disease.
    Pineton de Chambrun M; Wechsler B; Geri G; Cacoub P; Saadoun D
    Autoimmun Rev; 2012 Aug; 11(10):687-98. PubMed ID: 22197900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology of Behçet's disease].
    Houman MH; Bel Feki N
    Rev Med Interne; 2014 Feb; 35(2):90-6. PubMed ID: 24210264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.
    Clemente A; Cambra A; Munoz-Saá I; Crespí C; Pallarés L; Juan A; Matamoros N; Julià MR
    Immunol Lett; 2010 Apr; 129(2):57-63. PubMed ID: 20167234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behçet's disease: An immunogenetic perspective.
    Salmaninejad A; Zamani MR; Shabgah AG; Hosseini S; Mollaei F; Hosseini N; Sahebkar A
    J Cell Physiol; 2019 Jun; 234(6):8055-8074. PubMed ID: 30341905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of streptococcal hypersensitivity in the pathogenesis of Behçet's Disease.
    Kaneko F; Oyama N; Yanagihori H; Isogai E; Yokota K; Oguma K
    Eur J Dermatol; 2008; 18(5):489-98. PubMed ID: 18693149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behçet's Disease: An Overview of Etiopathogenesis.
    Leccese P; Alpsoy E
    Front Immunol; 2019; 10():1067. PubMed ID: 31134098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behçet's disease from the aspect of autoinflammatory disease].
    Ishigatsubo Y; Samukawa S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):408-19. PubMed ID: 22041429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behçet's disease: New insights into pathophysiology, clinical features and treatment options.
    Greco A; De Virgilio A; Ralli M; Ciofalo A; Mancini P; Attanasio G; de Vincentiis M; Lambiase A
    Autoimmun Rev; 2018 Jun; 17(6):567-575. PubMed ID: 29631062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease.
    Duymaz-Tozkir J; Yilmaz V; Uyar FA; Hajeer AH; Saruhan-Direskeneli G; Gül A
    J Rheumatol; 2005 Jan; 32(1):93-7. PubMed ID: 15630732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease.
    Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir MS; Feki M; Hamzaoui K
    Mediators Inflamm; 2004 Aug; 13(4):247-53. PubMed ID: 15545055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.
    Geri G; Terrier B; Rosenzwajg M; Wechsler B; Touzot M; Seilhean D; Tran TA; Bodaghi B; Musset L; Soumelis V; Klatzmann D; Cacoub P; Saadoun D
    J Allergy Clin Immunol; 2011 Sep; 128(3):655-64. PubMed ID: 21724243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines and Behcet's disease.
    Zhou ZY; Chen SL; Shen N; Lu Y
    Autoimmun Rev; 2012 Aug; 11(10):699-704. PubMed ID: 22197901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease: ocular effects and treatment.
    Deuter CM; Kötter I; Wallace GR; Murray PI; Stübiger N; Zierhut M
    Prog Retin Eye Res; 2008 Jan; 27(1):111-36. PubMed ID: 18035584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers.
    Bank I; Duvdevani M; Livneh A
    J Lab Clin Med; 2003 Jan; 141(1):33-40. PubMed ID: 12518166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype association of IL-8 gene with Behcet's disease.
    Lee EB; Kim JY; Zhao J; Park MH; Song YW
    Tissue Antigens; 2007 Feb; 69(2):128-32. PubMed ID: 17257314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B51 subtypes in Turkish patients with Behçet's disease and their correlation with clinical manifestations.
    Demirseren DD; Ceylan GG; Akoglu G; Emre S; Erten S; Arman A; Metin A
    Genet Mol Res; 2014 Jul; 13(3):4788-96. PubMed ID: 25062414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches.
    Salmaninejad A; Gowhari A; Hosseini S; Aslani S; Yousefi M; Bahrami T; Ebrahimi M; Nesaei A; Zal M
    J Immunotoxicol; 2017 Dec; 14(1):137-151. PubMed ID: 28693405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
    Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation.
    Freysdottir J; Hussain L; Farmer I; Lau SH; Fortune F
    Oral Dis; 2006 May; 12(3):271-7. PubMed ID: 16700735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.